Martin Mackay - Jul 29, 2024 Form 4 Insider Report for SpringWorks Therapeutics, Inc. (SWTX)

Role: Director
Signature: /s/ Francis I. Perier, Jr. as Attorney-in Fact
Stock symbol: SWTX
Transactions as of: Jul 29, 2024
Transactions value $: $0
Form type: 4
Date filed: 7/30/2024, 04:10 PM
Previous filing: May 15, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SWTX	Common Stock	Award	$0	+9.96K		$0.00	9.96K	Jul 29, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SWTX	Stock Option (Right to Buy)	Award	$0	+29.4K		$0.00	29.4K	Jul 29, 2024	Common Stock	29.4K	$36.80	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction represents a grant of restricted stock units ("RSUs") pursuant to the terms of the Issuer's Amended and Restated Non-Employee Director Compensation Policy which provides for initial equity grants to the Issuer's non-employee directors on the date of the Reporting Person's commencement of service to the Issuer. The RSUs shall vest in three (3) equal annual installments following July 29, 2024, subject to continued service to the Issuer by the Reporting Person.
F2	This transaction represents a grant of options pursuant to the terms of the Issuer's Amended and Restated Non-Employee Director Compensation Policy which provides for initial equity grants to the Issuer's non-employee directors on the date of the Reporting Person's commencement of service to the Issuer.
F3	The options shall vest in equal monthly installments over 36 months following July 29, 2024, subject to continued service to the Issuer by the Reporting Person.